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A B S T R A C T
Decompressive Craniectomy (DC) is a treatment option for severe brain injury (SBI). This method is applied when the
growth of intracranial pressure (ICP) can no longer be controlled with conservative methods. DC belongs to class III
»Guidelines« – »option« which has not clear clinical certainty. They do not correspond to »Standards« (class I) in treat-
ment protocol for SBI, which is common in most neurotraumatological centers. We have analyzed retrospectively 95 pa-
tients with SBI who were admitted to the Clinical Hospital Centre Rijeka. All patients were managed based on a protocol
of current Brain Trauma Foundations (BTF) Guidelines. 39 patients underwent DC while 34 patients underwent stan-
dard craniotomy. 22 patients did not undergo any surgical procedures. In each patient we analyzed ICP changes within
the first 11 days and in that way we correlated them statistically with the initial Glasgow Coma Scale (GCS) and then
with Glasgow Outcome Scale (GOS), after the end of the treatment. We particularly analyzed the outcome with reference
to the time of the operation and the size of DC. The standard measurement of ICP shows statistical significance in recov-
ery in the group without DC after 5 days of intensive treatment, when the pressure is stabilized between 20–25 mm Hg.
The stabilization of ICP in the DC group is observed already after 3 days of intensive treatment. Furthermore, better
functional recovery according to GOS, which is statistically significant, was observed in patients who underwent DC
where the area of craniectomy was larger than 25 cm2, within the first 24 hours from the time of injury. The use of DC
considerably reduces the need for CT check-ups. Increase in the number of encephalocele was noted, which is to be ex-
pected considering that dural decompression is used in DC procedure. The results of our study indicate that the utiliza-
tion of DC is characterized with lower mortality and better functional recovery if it is applied at an early stage of treat-
ment and if the size of DC is satisfactory.
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Introduction
Decompressive Craniectomy (DC) is a treatment op-
tion for severe brain injury (SBI). Namely, a number of
studies have indicated the importance of DC in reducing
morbidity and mortality in patients with SBI1–4. How-
ever, this method has not yet been listed as Standard, i.e.,
Level I of the International protocol but is cautiously rec-
ommended as a treatment option for selected patients5–7.
SBI is a large public health problem with a high mortal-
ity rate, especially in younger patients (up to 40 years of
age)8,9. DC lowers the intracranial pressure (ICP) and en-
hances neurological recovery in animal models with
SBI10–12. In certain studies there was improvement and
better recovery in patients1–4,13–15, while in other studies
this was not the case16,17. Due to development of cerebral
edema, which most often leads to fatal outcome, and the
fact that conservative methods of treatment do not al-
ways produce desired results, DC is classified as recom-
mendation Level III, i.e., a treatment option for SBI5–7.
Published literature implies that the method is occasion-
ally used. What is known about damaging effects of sub-
sequent brain injury for which there is no ideal treat-
ment still poses difficult questions for scientists and
doctors8,9. However, because it maintains a moderate de-
gree of clinical certainty, DC is not classified as standard
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in guidelines for treatment of SBI. Therefore, many
neuro-traumatological centers do not use it for this pa-
thology. The perception of DC as a high-risk invasive
treatment compared to non-surgical treatment arises
from the lack of extensive studies and published data on
successfulness of the procedure. In the available litera-
ture for SBI as one of the indications for DC, so far there
has not been a single large randomized study, only the
ones for neurological and cardiovascular disorders. Be-
cause of the lack of definitive evidence and clear recom-
mendations for use of DC in SBI treatment, additional
clinical studies for application of this treatment for SBI
are needed. The aim of this study is to analyze prospec-
tively gathered data obtained from SBI patients managed
at the Clinical Hospital Centre Rijeka, and perform compa-
rative analysis in relation to the applied method of treat-
ment and contribution to better functional outcome.
This surgical method is often followed by complications
that range from 6–7% for local and central infections, to
15–20% for encephalocele and hydrocephalus1–4,14,18–22.
Patients and Methods
The study included 95 patients with SBI, who were
admitted to and treated at Clinical Hospital Centre Rije-
ka between 1 January 2002 and 31 December 2008. In all
patients the following criteria were applied: SBI, Glas-
gow Coma Score (GCS)23 equal to or less than 8, CT-de-
termined SBI with a brain edema, extradural and/ or
subdural brain hemorrhage with a midline shift of maxi-
mum 1 cm, age between 15 and 65 years, hospitalization
within 48 hours from the time of the injury. An intra-
ventricular ICP monitoring system was set up with all
patients. GCS was routinely monitored upon admittance.
Patients with SBI and bilateral nonreactive pupils larger
than 5 mm, and patients with a severe neck marrow in-
jury and intracranial hemorrhage where midline shift
was more than 1 cm, were excluded from the study. In all
patients ICP changes were analyzed in first 11 and func-
tional recovery was monitored with Glasgow Outcome
Score scale at discharge from the hospital with a fol-
low-up due in six months24. All patients were treated in
the Intensive Care Unit (ICU) according to standard
Guidelines for SBI treatment5–7. Out of 95 patients with
SBI, 39 were treated for malignant cerebral edema with
or without extra-axial hemorrhage using DC. The ap-
plied DC involved unilateral bone fragment removal and
duroplasty was performed with the help of temporal
muscle / fascia. In 34 patients standard craniotomy was
performed due to borderline results of compression effect
of medial shift of 1 cm, but with a large haemorrhage
area. 22 patients did not undergo any surgical procedure,
except that standard intraventricular ICP monitoring
was set up.
Statistics
The numerical data is represented with median and
range, and with categorical absolute (N) and relative
(share %) of incidence. The comparison between the nu-
merical data was done by non-parametric tests, while the
comparison of the distribution between the groups was
analyzed with c2-test and Fisher’s exact test.
Results
Statistical analysis has shown that with conservative
treatment monitoring the ICP dynamics, there was sig-
nificant recovery after five days, when ICP is stabilized
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TABLE 1
THE VALUES OF INTRACRANIAL PRESSURE (ICP) ON THE FIRST, THIRD AND FIFTH DAY IN RELATION TO PERFORMED
DECOMPRESSIVE CRANIECTOMY, EXPRESSED IN ABSOLUTE AND RELATIVE INCIDENCE(N, %)
ICP
DC not performed DC within 24 hours DC after 24 hours
P – x2 test
No of cases % No of cases % No of cases %
1. day < 25 mmHg 45 80.4 12 30.8 0 0
0.001
> 25 mmHg 11 19.6 18 46.2 9 23.0
3. day < 25 mmHg 14 25.0 18 46.2 1 2.5
> 25 mmHg 42 75.0 12 30.8 8 20.5
5. day < 25 mmHg 30 53.6 25 64.2 2 5.1
> 25 mmHg 26 46.4 5 12.8 7 17.9
TABLE 2
GOS VALUES IN RELATION TO THE AREA OF DECOMPRESSIVE CRANIECTOMY, EXPRESSED IN ABSOLUTE AND RELATIVE
INCIDENCE (N, %)
Area of DC
GOS 1 GOS 2–3 GOS 4–5 TOTAL
P – c2 test
No of cases % No of cases % No of cases % No of cases %
< 15 cm2 8 20.5 6 15.4 0 0 14 35.9 0.001
15–25 cm2 3 7.7 7 17.9 4 10.3 14 35.9
> 25 cm2 0 0 1 2.6 10 25.6 11 28.2
between 20–25 mm Hg, whereas in patients where addi-
tional DC stabilization of ICP was performed, the recov-
ery can already be observed after 3 days of treatment
(Table 1). Furthermore, better functional recovery ac-
cording to GOS is statistically clearly expressed and visi-
ble in patients who underwent DC where the area of
craniectomy was larger than 25 cm2, especially if it was
performed within the first 24 hours after admittance
(Table 2). Analysis of the number of radiological fol-
low-up examinations (CT) indicates that patients with
DC require significantly fewer CT follow-up examina-
tions (Table 3). However, using DC as optional additional
treatment of SBI has as a consequence surgical complica-
tions. Table 4 shows complications in patients who un-
derwent DC. Increase in the number of encephalocele
was noted, which is to be expected considering that dural
decompression is used in DC procedure (Table 4).
Discussion
The crucial question concerning the use of DC in SBI
treatment is whether decompressive craniectomy helps
to control the ICP in early posttraumatic period during
intensive treatment, and whether its potential benefits
are greater than risks of existing complications. Data in
the literature indicate that in short-term monitoring
there is improvement in ICP control and survival rate.
However, a number of results indicate that there are
complications in early stages, as well as in long-term
monitoring. In our study we have monitored only the
short-term outcome of intensive SBI treatment. Impor-
tant indicators, such as ICP monitoring and survival
rate, show the importance and need of the use of DC,
which is in accordance with the results of other authors.
In the conducted study a small number of complications
were registered, such as the occurrence of encephalocele,
haemorrhage and infection, but fatal outcome was more
frequent in patients who had not undergone DC. Long-
-term monitoring of SBI patients who underwent DC
additionally1–3,18–20, the results of cranioplasty of a defect
retained after DC, and of neurorehabilitation, as well as
a possible subsequent internal hydrocephalus have not
been the subject of this study and will be shown subse-
quently.
Conclusion
The results in treatment of SBI using DC in our study
indicate the importance and need of the use of DC, be-
cause it contributes to statistically significant more suc-
cessful treatment of SBI. Additional use of DC in relation
to non-surgical methods described in Level I of SBI pro-
tocol of the »Guidelines« indicates the merit of the proce-
dure. It is a promising procedure for a selected group of
SBI patients because ICP values are lowered far sooner
than without DC. All that has as a consequence lower
mortality and better functional recovery if it is applied at
an early stage of treatment and if the size of DC is satis-
factory. In order for DC to become classified in standard
guidelines for SBI treatment, an analysis of a large num-
ber of SBI patients is necessary, in several referential
neurotraumatological centres according to strictly estab-
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TABLE 3
THE NUMBER OF CT FOLLOW-UP EXAMINATIONS IN RELATION TO PERFORMED DECOMPRESSIVE CRANIECTOMY,
EXPRESSED IN ABSOLUTE AND RELATIVE INCIDENCE (N, %)
Decompressive
craniectomy
DC not performed DC within 24 hours DC after 24 hours All groups together
P – c2 test




2 26 27.4 12 12.6 0 0 38 40.0 0.003
3 28 29.5 15 15.8 5 5.3 48 50.5
4 3 3.2 1 1.1 4 4.2 8 8.4
5 1 1.1 0 0 0 0 1 1.1
TABLE 4
OCCURRENCE OF COMPLICATIONS IN RELATION TO PERFORMED DECOMPRESSIVE CRANIECTOMY,










No of cases % No of cases % No of cases % No of cases %
No complications 46 48.4 13 13.7 2 2.1 61 64.2 0.001
Complications Bleeding 2 2.1 2 2.1 2 2.1 6 6.3
Brain fungus 0 0 13 13.7 2 2.1 15 15.8
Infection 3 3.1 1 1.1 1 1.1 5 5.3
Death 5 5.2 1 1.1 2 2.1 8 8.4
lished criteria and the choice of patients. Such analysis
would help to standardize the technique for the size of
DC and the method of dural decompression. Considering
the variety of data in studies so far, we believe that the
conducted research will help many in their choice of this
surgical method in SBI treatment protocol.
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U^INKOVITOST LIJE^ENJA TE[KIH OZLJEDA MOZGA PRIMJENOM DEKOMPRESIVNE
KRANIEKTOMIJE U KBC RIJEKA
S A @ E T A K
Dekompresivna kraniektomija (DK) je opcija lije~enja te{ke ozljede mozga (TOM). Ovu metodu primjenjujemo kad
se vi{e ne mo`e kontrolirati rast intrakranijskog mo`danog tlaka (IMT) konzervativnim metodama. DK spada u III
razinu smjernica – »opcije« koje nemaju jasnu klini~ku sigurnost. One se ne uklapaju u standard I razine protokola za
lije~enje TOM koja je ina~e uobi~ajna u najve}em broju neurotraumatolo{kih centara. U na{oj studiji obradili smo
retrospektivno 95 bolesnika sa TOM zbrinutih u KBC Rijeka. Pacijenti su zbrinuti po protokolu »Brain Trauma Foun-
dation« (BTF) za TOM. 39 pacijenata podvrgnuto je primjeni DK dok je u 34 pacijenta u~injena standardna kranio-
tomija. U 22 pacijenta nije u~injen nikakav kirur{ki zahvat. Kod svih bolesnika analizirali smo promjene IMT u prvih
11 dana te statisti~ki korelirali sa inicijalnim »Glasgow Coma Scale« (GCS), i potom sa »Glasgow Outcome Scale«
(GOS) po zavr{etku lije~enju. Posebno smo analizirali ishod u odnosu na vrijeme operacije i povr{inu DK. Vrijednosti
IMT pokazale su da u pacijenta gdje nije u~injena DK stabiliziranje IMT (izme|u 20–25 mmHg) nastupa nakon 5 dana
intezivnog lije~enja dok u pacijenata s DK spomenuti oporavak nastupa ve} tre}eg dana lije~enja. Tako|er bolji funk-
cionalni oporavak po GOS, koji je statisti~ki jasno izra`en, vidljiv je kod bolesnika kod kojih je u~injena DK-a povr{ine
ve}e od 25 cm2 u prvih 24 sata. Primjenom DK smanjen je broj CT kontrola. Evidentiran je porast broja encefalokela {to
je i razumljivo s obzirom da se u postupku DK vr{i i duralna dekompresija. Rezultati istar`ivanja ukazuju na va`nost
DK koju karakteriziraju smanjenje smrtnosti i bolji funkcionalni oporavka ukoliko se provodi u ranoj fazi lije~enja i
odgovaraju}om povr{inom DK.
